Skip to content

PROOF Centre

Menu

  • Home
  • About
    • Our Team
    • Alumni
    • Our Community of Partners
  • Our Programs
    • Patents
    • Biomarkers for Improved Management of Chronic Obstructive Pulmonary Disease (COPD)
    • Biomarkers for Improved Monitoring of Immune Rejection in Heart Transplantation
    • Spotlight Series
  • Our Services
  • Biomarker Webinars
  • News Room
    • News
    • Events
    • Media Coverage
    • Press Releases
      • PROOF Centre Collaboration Focuses on Prognostic Biomarkers for Chronic Kidney Disease
      • PROOF Centre to Begin Clinical Validation of Heart Transplant Rejection Liquid Biopsy Test Using the HTG EdgeSeq System, a Next-Generation Sequencing (NGS)-Based Platform
      • Mapping BC’s Path to Personalized Medicine
      • PROOF Centre & IO Informatics to Present at Partnering for Cures Conference
      • Centres of Excellence Align to Advance Novel Therapeutics and Diagnostics
      • PROOF Centre and MRM Proteomics Collaborate with the Jain Foundation to Identify Blood-Based Biomarkers of LGMD2B/Miyoshi Muscular Dystrophy
      • The PROOF Centre of Excellence Partners with HTG Molecular Diagnostics to Begin Clinical Validation of Heart Transplant Rejection Blood Test
      • PROOF Centre of Excellence and MRM Proteomics Partner to Bring New Tests to Clinic
      • New Blood Tests to put Clinical Trials for Allergic Asthma on the Fast Track
      • New Web-based App to Help Clinicians Improve Patient Care
      • The PROOF Centre of Excellence Partners with OriGene Technologies on Heart & Kidney Transplant Biomarker Program
      • Time to breathe a sigh of relief
      • PROOF Centre and Adiga Life Sciences launch biomarker discovery collaboration
  • Publications
  • Contact Us
PROOF Centre

Antiviral Drug Used to Treat Hep-C Could Help COVID Patients – The Daily Scan

The latest issue of the Daily Scan by Providence Health Care features PROOF Centre’s recent study on the use of an antiviral drug that could help COVID-19 patients.

Read the full article here. 

Antiviral Drug Used to Treat Hep-C Could Help COVID Patients – The Daily Scan
Tagged on: COVID    covid19    drugs    healthcare    patientcare    research
Casey Shannon 2020-04-292020-04-29 News
  • ← Annual Heart Transplant Patient Education Day: Mission I’Mpossible!
  • Appointment of Dr. Suzanne Vercauteren to the Board of Directors →

About the PROOF Centre

The PROOF (Prevention of Organ Failure) Centre of Excellence is a not-for-profit organization that develops blood tests to better predict, diagnose, manage and treat disease, by harnessing the power of clinical, molecular and computational science.

Follow us

Copyright © 2024 PROOF Centre. All rights reserved. Theme Spacious by ThemeGrill. Powered by: WordPress.